Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer.

Author: DenisL, MahlerC, VerhelstJ

Paper Details 
Original Abstract of the Article :
Prostatic cancer is the second most common cause of cancer death in males. Treatment by radical prostatectomy and radiotherapy is useful in the early stages of the disease. Whenever metastases occur, patients are usually treated by surgical (orchidectomy) or medical [gonadotropin releasing hormone (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2165/00003088-199834050-00005

データ提供:米国国立医学図書館(NLM)

Prostate Cancer: A Desert of Hormonal Warfare

Prostate cancer is a challenging foe, a formidable desert to conquer. This study explores the use of antiandrogens in the treatment of prostate cancer, a battleground where hormones play a crucial role. The researchers discuss the different types of antiandrogens and their effectiveness in blocking androgen activity, the key to controlling the growth of this aggressive cancer. This study is like a detailed battle plan, outlining the different strategies for fighting prostate cancer with antiandrogens.

Antiandrogens: Weapons in the Hormonal War

This study sheds light on the use of antiandrogens in prostate cancer treatment. These drugs, like potent weapons, block androgen activity, hindering the growth and spread of this aggressive cancer.

Navigating the Complexities of Prostate Cancer Treatment

The realm of prostate cancer treatment is a complex and often challenging desert. This study offers valuable insights into the use of antiandrogens, a potential oasis of relief for patients battling this disease. Further research is needed to refine our understanding of these treatments and explore their potential for combination therapies, but this study offers a valuable contribution to our arsenal of weapons against this formidable foe.

Dr.Camel's Conclusion

This study provides a valuable overview of antiandrogen therapy in prostate cancer. These drugs, like powerful weapons, block androgen activity, a key factor in the growth and spread of this disease. By understanding the different types of antiandrogens and their potential benefits and risks, we can better navigate the challenging desert of prostate cancer treatment and develop more effective strategies for battling this formidable foe.

Date :
  1. Date Completed 1998-07-23
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

9592622

DOI: Digital Object Identifier

10.2165/00003088-199834050-00005

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.